aluates Reports

$ 0.0

Automative

Global C1 Esterase Inhibitor Subcutaneous Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-22X12742

Global C1 Esterase Inhibitor Subcutaneous Market Research Report 2023

BUY CHAPTERS

Global C1 Esterase Inhibitor Subcutaneous Market Research Report 2025

Code: QYRE-Auto-22X12742

Report

May 2025

Pages:74

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Takeda

CSL Behring

C1 Esterase Inhibitor Subcutaneous Market Size

The global market for C1 Esterase Inhibitor Subcutaneous was valued at US$ 714 million in the year 2024 and is projected to reach a revised size of US$ 1270 million by 2031, growing at a CAGR of 8.7% during the forecast period.

C1 Esterase Inhibitor Subcutaneous Market

C1 esterase inhibitor is used to treat or prevent hereditary angioedema (HAE).

The C1 esterase inhibitor subcutaneous market is driven by a growing awareness and diagnosis of hereditary angioedema (HAE) and other related disorders. As more patients are identified and diagnosed with these conditions, there is an increasing demand for effective treatment options like subcutaneous C1 esterase inhibitors. Additionally, advancements in biotechnology and medical research have led to the development of novel therapies, further fueling market growth. However, the market also faces challenges, such as high treatment costs and limited accessibility to these specialized therapies. Additionally, stringent regulatory requirements and the need for robust clinical evidence for new products present hurdles for companies operating in this sector. Overcoming these challenges while addressing the unmet medical needs of patients will be crucial for sustained growth in the C1 esterase inhibitor subcutaneous market.

Report Scope

This report aims to provide a comprehensive presentation of the global market for C1 Esterase Inhibitor Subcutaneous, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding C1 Esterase Inhibitor Subcutaneous.

The C1 Esterase Inhibitor Subcutaneous market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global C1 Esterase Inhibitor Subcutaneous market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the C1 Esterase Inhibitor Subcutaneous manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of C1 Esterase Inhibitor Subcutaneous Market Report

Report Metric	Details
Report Name	C1 Esterase Inhibitor Subcutaneous Market
Accounted market size in year	US$ 714 million
Forecasted market size in 2031	US$ 1270 million
CAGR	8.7%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	500U 1000U
Segment by Application	Children Adult
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Takeda, CSL Behring
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of C1 Esterase Inhibitor Subcutaneous manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of C1 Esterase Inhibitor Subcutaneous in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is C1 Esterase Inhibitor Subcutaneous Market growing?

Ans: The C1 Esterase Inhibitor Subcutaneous Market witnessing a CAGR of 8.7% during the forecast period 2025-2031.

What is the C1 Esterase Inhibitor Subcutaneous Market size in 2031?

Ans: The C1 Esterase Inhibitor Subcutaneous Market size in 2031 will be US$ 1270 million.

Who are the main players in the C1 Esterase Inhibitor Subcutaneous Market report?

Ans: The main players in the C1 Esterase Inhibitor Subcutaneous Market are Takeda, CSL Behring

What are the Application segmentation covered in the C1 Esterase Inhibitor Subcutaneous Market report?

Ans: The Applications covered in the C1 Esterase Inhibitor Subcutaneous Market report are Children, Adult

What are the Type segmentation covered in the C1 Esterase Inhibitor Subcutaneous Market report?

Ans: The Types covered in the C1 Esterase Inhibitor Subcutaneous Market report are 500U, 1000U

Recommended Reports

Dermatology and Skin

Autoimmune & Allergies

Subcutaneous Delivery

1 C1 Esterase Inhibitor Subcutaneous Market Overview

1.1 Product Definition

1.2 C1 Esterase Inhibitor Subcutaneous by Type

1.2.1 Global C1 Esterase Inhibitor Subcutaneous Market Value Comparison by Type (2024 VS 2031)

1.2.2 500U

1.2.3 1000U

1.3 C1 Esterase Inhibitor Subcutaneous by Application

1.3.1 Global C1 Esterase Inhibitor Subcutaneous Market Value by Application (2024 VS 2031)

1.3.2 Children

1.3.3 Adult

1.4 Global C1 Esterase Inhibitor Subcutaneous Market Size Estimates and Forecasts

1.4.1 Global C1 Esterase Inhibitor Subcutaneous Revenue 2020-2031

1.4.2 Global C1 Esterase Inhibitor Subcutaneous Sales 2020-2031

1.4.3 Global C1 Esterase Inhibitor Subcutaneous Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 C1 Esterase Inhibitor Subcutaneous Market Competition by Manufacturers

2.1 Global C1 Esterase Inhibitor Subcutaneous Sales Market Share by Manufacturers (2020-2025)

2.2 Global C1 Esterase Inhibitor Subcutaneous Revenue Market Share by Manufacturers (2020-2025)

2.3 Global C1 Esterase Inhibitor Subcutaneous Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of C1 Esterase Inhibitor Subcutaneous, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of C1 Esterase Inhibitor Subcutaneous, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of C1 Esterase Inhibitor Subcutaneous, Product Type & Application

2.7 Global Key Manufacturers of C1 Esterase Inhibitor Subcutaneous, Date of Enter into This Industry

2.8 Global C1 Esterase Inhibitor Subcutaneous Market Competitive Situation and Trends

2.8.1 Global C1 Esterase Inhibitor Subcutaneous Market Concentration Rate

2.8.2 The Global 5 and 10 Largest C1 Esterase Inhibitor Subcutaneous Players Market Share by Revenue

2.8.3 Global C1 Esterase Inhibitor Subcutaneous Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global C1 Esterase Inhibitor Subcutaneous Market Scenario by Region

3.1 Global C1 Esterase Inhibitor Subcutaneous Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global C1 Esterase Inhibitor Subcutaneous Sales by Region: 2020-2031

3.2.1 Global C1 Esterase Inhibitor Subcutaneous Sales by Region: 2020-2025

3.2.2 Global C1 Esterase Inhibitor Subcutaneous Sales by Region: 2026-2031

3.3 Global C1 Esterase Inhibitor Subcutaneous Revenue by Region: 2020-2031

3.3.1 Global C1 Esterase Inhibitor Subcutaneous Revenue by Region: 2020-2025

3.3.2 Global C1 Esterase Inhibitor Subcutaneous Revenue by Region: 2026-2031

3.4 North America C1 Esterase Inhibitor Subcutaneous Market Facts & Figures by Country

3.4.1 North America C1 Esterase Inhibitor Subcutaneous Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America C1 Esterase Inhibitor Subcutaneous Sales by Country (2020-2031)

3.4.3 North America C1 Esterase Inhibitor Subcutaneous Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe C1 Esterase Inhibitor Subcutaneous Market Facts & Figures by Country

3.5.1 Europe C1 Esterase Inhibitor Subcutaneous Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe C1 Esterase Inhibitor Subcutaneous Sales by Country (2020-2031)

3.5.3 Europe C1 Esterase Inhibitor Subcutaneous Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific C1 Esterase Inhibitor Subcutaneous Market Facts & Figures by Region

3.6.1 Asia Pacific C1 Esterase Inhibitor Subcutaneous Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific C1 Esterase Inhibitor Subcutaneous Sales by Region (2020-2031)

3.6.3 Asia Pacific C1 Esterase Inhibitor Subcutaneous Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America C1 Esterase Inhibitor Subcutaneous Market Facts & Figures by Country

3.7.1 Latin America C1 Esterase Inhibitor Subcutaneous Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America C1 Esterase Inhibitor Subcutaneous Sales by Country (2020-2031)

3.7.3 Latin America C1 Esterase Inhibitor Subcutaneous Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa C1 Esterase Inhibitor Subcutaneous Market Facts & Figures by Country

3.8.1 Middle East and Africa C1 Esterase Inhibitor Subcutaneous Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa C1 Esterase Inhibitor Subcutaneous Sales by Country (2020-2031)

3.8.3 Middle East and Africa C1 Esterase Inhibitor Subcutaneous Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global C1 Esterase Inhibitor Subcutaneous Sales by Type (2020-2031)

4.1.1 Global C1 Esterase Inhibitor Subcutaneous Sales by Type (2020-2025)

4.1.2 Global C1 Esterase Inhibitor Subcutaneous Sales by Type (2026-2031)

4.1.3 Global C1 Esterase Inhibitor Subcutaneous Sales Market Share by Type (2020-2031)

4.2 Global C1 Esterase Inhibitor Subcutaneous Revenue by Type (2020-2031)

4.2.1 Global C1 Esterase Inhibitor Subcutaneous Revenue by Type (2020-2025)

4.2.2 Global C1 Esterase Inhibitor Subcutaneous Revenue by Type (2026-2031)

4.2.3 Global C1 Esterase Inhibitor Subcutaneous Revenue Market Share by Type (2020-2031)

4.3 Global C1 Esterase Inhibitor Subcutaneous Price by Type (2020-2031)

5 Segment by Application

5.1 Global C1 Esterase Inhibitor Subcutaneous Sales by Application (2020-2031)

5.1.1 Global C1 Esterase Inhibitor Subcutaneous Sales by Application (2020-2025)

5.1.2 Global C1 Esterase Inhibitor Subcutaneous Sales by Application (2026-2031)

5.1.3 Global C1 Esterase Inhibitor Subcutaneous Sales Market Share by Application (2020-2031)

5.2 Global C1 Esterase Inhibitor Subcutaneous Revenue by Application (2020-2031)

5.2.1 Global C1 Esterase Inhibitor Subcutaneous Revenue by Application (2020-2025)

5.2.2 Global C1 Esterase Inhibitor Subcutaneous Revenue by Application (2026-2031)

5.2.3 Global C1 Esterase Inhibitor Subcutaneous Revenue Market Share by Application (2020-2031)

5.3 Global C1 Esterase Inhibitor Subcutaneous Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Takeda

6.1.1 Takeda Company Information

6.1.2 Takeda Description and Business Overview

6.1.3 Takeda C1 Esterase Inhibitor Subcutaneous Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Takeda C1 Esterase Inhibitor Subcutaneous Product Portfolio

6.1.5 Takeda Recent Developments/Updates

6.2 CSL Behring

6.2.1 CSL Behring Company Information

6.2.2 CSL Behring Description and Business Overview

6.2.3 CSL Behring C1 Esterase Inhibitor Subcutaneous Sales, Revenue and Gross Margin (2020-2025)

6.2.4 CSL Behring C1 Esterase Inhibitor Subcutaneous Product Portfolio

6.2.5 CSL Behring Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 C1 Esterase Inhibitor Subcutaneous Industry Chain Analysis

7.2 C1 Esterase Inhibitor Subcutaneous Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 C1 Esterase Inhibitor Subcutaneous Production Mode & Process Analysis

7.4 C1 Esterase Inhibitor Subcutaneous Sales and Marketing

7.4.1 C1 Esterase Inhibitor Subcutaneous Sales Channels

7.4.2 C1 Esterase Inhibitor Subcutaneous Distributors

7.5 C1 Esterase Inhibitor Subcutaneous Customer Analysis

8 C1 Esterase Inhibitor Subcutaneous Market Dynamics

8.1 C1 Esterase Inhibitor Subcutaneous Industry Trends

8.2 C1 Esterase Inhibitor Subcutaneous Market Drivers

8.3 C1 Esterase Inhibitor Subcutaneous Market Challenges

8.4 C1 Esterase Inhibitor Subcutaneous Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Takeda

CSL Behring

List of Tables

Table 1. Global C1 Esterase Inhibitor Subcutaneous Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global C1 Esterase Inhibitor Subcutaneous Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global C1 Esterase Inhibitor Subcutaneous Market Competitive Situation by Manufacturers in 2024

Table 4. Global C1 Esterase Inhibitor Subcutaneous Sales (Units) of Key Manufacturers (2020-2025)

Table 5. Global C1 Esterase Inhibitor Subcutaneous Sales Market Share by Manufacturers (2020-2025)

Table 6. Global C1 Esterase Inhibitor Subcutaneous Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global C1 Esterase Inhibitor Subcutaneous Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market C1 Esterase Inhibitor Subcutaneous Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of C1 Esterase Inhibitor Subcutaneous, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of C1 Esterase Inhibitor Subcutaneous, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of C1 Esterase Inhibitor Subcutaneous, Product Type & Application

Table 12. Global Key Manufacturers of C1 Esterase Inhibitor Subcutaneous, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global C1 Esterase Inhibitor Subcutaneous by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in C1 Esterase Inhibitor Subcutaneous as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global C1 Esterase Inhibitor Subcutaneous Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global C1 Esterase Inhibitor Subcutaneous Sales by Region (2020-2025) & (Units)

Table 18. Global C1 Esterase Inhibitor Subcutaneous Sales Market Share by Region (2020-2025)

Table 19. Global C1 Esterase Inhibitor Subcutaneous Sales by Region (2026-2031) & (Units)

Table 20. Global C1 Esterase Inhibitor Subcutaneous Sales Market Share by Region (2026-2031)

Table 21. Global C1 Esterase Inhibitor Subcutaneous Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global C1 Esterase Inhibitor Subcutaneous Revenue Market Share by Region (2020-2025)

Table 23. Global C1 Esterase Inhibitor Subcutaneous Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global C1 Esterase Inhibitor Subcutaneous Revenue Market Share by Region (2026-2031)

Table 25. North America C1 Esterase Inhibitor Subcutaneous Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America C1 Esterase Inhibitor Subcutaneous Sales by Country (2020-2025) & (Units)

Table 27. North America C1 Esterase Inhibitor Subcutaneous Sales by Country (2026-2031) & (Units)

Table 28. North America C1 Esterase Inhibitor Subcutaneous Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America C1 Esterase Inhibitor Subcutaneous Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe C1 Esterase Inhibitor Subcutaneous Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe C1 Esterase Inhibitor Subcutaneous Sales by Country (2020-2025) & (Units)

Table 32. Europe C1 Esterase Inhibitor Subcutaneous Sales by Country (2026-2031) & (Units)

Table 33. Europe C1 Esterase Inhibitor Subcutaneous Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe C1 Esterase Inhibitor Subcutaneous Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific C1 Esterase Inhibitor Subcutaneous Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific C1 Esterase Inhibitor Subcutaneous Sales by Region (2020-2025) & (Units)

Table 37. Asia Pacific C1 Esterase Inhibitor Subcutaneous Sales by Region (2026-2031) & (Units)

Table 38. Asia Pacific C1 Esterase Inhibitor Subcutaneous Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific C1 Esterase Inhibitor Subcutaneous Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America C1 Esterase Inhibitor Subcutaneous Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America C1 Esterase Inhibitor Subcutaneous Sales by Country (2020-2025) & (Units)

Table 42. Latin America C1 Esterase Inhibitor Subcutaneous Sales by Country (2026-2031) & (Units)

Table 43. Latin America C1 Esterase Inhibitor Subcutaneous Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America C1 Esterase Inhibitor Subcutaneous Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa C1 Esterase Inhibitor Subcutaneous Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa C1 Esterase Inhibitor Subcutaneous Sales by Country (2020-2025) & (Units)

Table 47. Middle East and Africa C1 Esterase Inhibitor Subcutaneous Sales by Country (2026-2031) & (Units)

Table 48. Middle East and Africa C1 Esterase Inhibitor Subcutaneous Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa C1 Esterase Inhibitor Subcutaneous Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global C1 Esterase Inhibitor Subcutaneous Sales (Units) by Type (2020-2025)

Table 51. Global C1 Esterase Inhibitor Subcutaneous Sales (Units) by Type (2026-2031)

Table 52. Global C1 Esterase Inhibitor Subcutaneous Sales Market Share by Type (2020-2025)

Table 53. Global C1 Esterase Inhibitor Subcutaneous Sales Market Share by Type (2026-2031)

Table 54. Global C1 Esterase Inhibitor Subcutaneous Revenue (US$ Million) by Type (2020-2025)

Table 55. Global C1 Esterase Inhibitor Subcutaneous Revenue (US$ Million) by Type (2026-2031)

Table 56. Global C1 Esterase Inhibitor Subcutaneous Revenue Market Share by Type (2020-2025)

Table 57. Global C1 Esterase Inhibitor Subcutaneous Revenue Market Share by Type (2026-2031)

Table 58. Global C1 Esterase Inhibitor Subcutaneous Price (US$/Unit) by Type (2020-2025)

Table 59. Global C1 Esterase Inhibitor Subcutaneous Price (US$/Unit) by Type (2026-2031)

Table 60. Global C1 Esterase Inhibitor Subcutaneous Sales (Units) by Application (2020-2025)

Table 61. Global C1 Esterase Inhibitor Subcutaneous Sales (Units) by Application (2026-2031)

Table 62. Global C1 Esterase Inhibitor Subcutaneous Sales Market Share by Application (2020-2025)

Table 63. Global C1 Esterase Inhibitor Subcutaneous Sales Market Share by Application (2026-2031)

Table 64. Global C1 Esterase Inhibitor Subcutaneous Revenue (US$ Million) by Application (2020-2025)

Table 65. Global C1 Esterase Inhibitor Subcutaneous Revenue (US$ Million) by Application (2026-2031)

Table 66. Global C1 Esterase Inhibitor Subcutaneous Revenue Market Share by Application (2020-2025)

Table 67. Global C1 Esterase Inhibitor Subcutaneous Revenue Market Share by Application (2026-2031)

Table 68. Global C1 Esterase Inhibitor Subcutaneous Price (US$/Unit) by Application (2020-2025)

Table 69. Global C1 Esterase Inhibitor Subcutaneous Price (US$/Unit) by Application (2026-2031)

Table 70. Takeda Company Information

Table 71. Takeda Description and Business Overview

Table 72. Takeda C1 Esterase Inhibitor Subcutaneous Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Takeda C1 Esterase Inhibitor Subcutaneous Product

Table 74. Takeda Recent Developments/Updates

Table 75. CSL Behring Company Information

Table 76. CSL Behring Description and Business Overview

Table 77. CSL Behring C1 Esterase Inhibitor Subcutaneous Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. CSL Behring C1 Esterase Inhibitor Subcutaneous Product

Table 79. CSL Behring Recent Developments/Updates

Table 80. Key Raw Materials Lists

Table 81. Raw Materials Key Suppliers Lists

Table 82. C1 Esterase Inhibitor Subcutaneous Distributors List

Table 83. C1 Esterase Inhibitor Subcutaneous Customers List

Table 84. C1 Esterase Inhibitor Subcutaneous Market Trends

Table 85. C1 Esterase Inhibitor Subcutaneous Market Drivers

Table 86. C1 Esterase Inhibitor Subcutaneous Market Challenges

Table 87. C1 Esterase Inhibitor Subcutaneous Market Restraints

Table 88. Research Programs/Design for This Report

Table 89. Key Data Information from Secondary Sources

Table 90. Key Data Information from Primary Sources

Table 91. Authors List of This Report

List of Figures

Figure 1. Product Picture of C1 Esterase Inhibitor Subcutaneous

Figure 2. Global C1 Esterase Inhibitor Subcutaneous Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global C1 Esterase Inhibitor Subcutaneous Market Share by Type: 2024 & 2031

Figure 4. 500U Product Picture

Figure 5. 1000U Product Picture

Figure 6. Global C1 Esterase Inhibitor Subcutaneous Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global C1 Esterase Inhibitor Subcutaneous Market Share by Application: 2024 & 2031

Figure 8. Children

Figure 9. Adult

Figure 10. Global C1 Esterase Inhibitor Subcutaneous Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global C1 Esterase Inhibitor Subcutaneous Market Size (2020-2031) & (US$ Million)

Figure 12. Global C1 Esterase Inhibitor Subcutaneous Sales (2020-2031) & (Units)

Figure 13. Global C1 Esterase Inhibitor Subcutaneous Average Price (US$/Unit) & (2020-2031)

Figure 14. C1 Esterase Inhibitor Subcutaneous Report Years Considered

Figure 15. C1 Esterase Inhibitor Subcutaneous Sales Share by Manufacturers in 2024

Figure 16. Global C1 Esterase Inhibitor Subcutaneous Revenue Share by Manufacturers in 2024

Figure 17. Global 5 and 10 Largest C1 Esterase Inhibitor Subcutaneous Players: Market Share by Revenue in C1 Esterase Inhibitor Subcutaneous in 2024

Figure 18. C1 Esterase Inhibitor Subcutaneous Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 19. Global C1 Esterase Inhibitor Subcutaneous Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 20. North America C1 Esterase Inhibitor Subcutaneous Sales Market Share by Country (2020-2031)

Figure 21. North America C1 Esterase Inhibitor Subcutaneous Revenue Market Share by Country (2020-2031)

Figure 22. United States C1 Esterase Inhibitor Subcutaneous Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 23. Canada C1 Esterase Inhibitor Subcutaneous Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Europe C1 Esterase Inhibitor Subcutaneous Sales Market Share by Country (2020-2031)

Figure 25. Europe C1 Esterase Inhibitor Subcutaneous Revenue Market Share by Country (2020-2031)

Figure 26. Germany C1 Esterase Inhibitor Subcutaneous Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. France C1 Esterase Inhibitor Subcutaneous Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. U.K. C1 Esterase Inhibitor Subcutaneous Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Italy C1 Esterase Inhibitor Subcutaneous Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Russia C1 Esterase Inhibitor Subcutaneous Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Asia Pacific C1 Esterase Inhibitor Subcutaneous Sales Market Share by Region (2020-2031)

Figure 32. Asia Pacific C1 Esterase Inhibitor Subcutaneous Revenue Market Share by Region (2020-2031)

Figure 33. China C1 Esterase Inhibitor Subcutaneous Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Japan C1 Esterase Inhibitor Subcutaneous Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. South Korea C1 Esterase Inhibitor Subcutaneous Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. India C1 Esterase Inhibitor Subcutaneous Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Australia C1 Esterase Inhibitor Subcutaneous Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. China Taiwan C1 Esterase Inhibitor Subcutaneous Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Southeast Asia C1 Esterase Inhibitor Subcutaneous Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Latin America C1 Esterase Inhibitor Subcutaneous Sales Market Share by Country (2020-2031)

Figure 41. Latin America C1 Esterase Inhibitor Subcutaneous Revenue Market Share by Country (2020-2031)

Figure 42. Mexico C1 Esterase Inhibitor Subcutaneous Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Brazil C1 Esterase Inhibitor Subcutaneous Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Argentina C1 Esterase Inhibitor Subcutaneous Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Colombia C1 Esterase Inhibitor Subcutaneous Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Middle East and Africa C1 Esterase Inhibitor Subcutaneous Sales Market Share by Country (2020-2031)

Figure 47. Middle East and Africa C1 Esterase Inhibitor Subcutaneous Revenue Market Share by Country (2020-2031)

Figure 48. Turkey C1 Esterase Inhibitor Subcutaneous Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Saudi Arabia C1 Esterase Inhibitor Subcutaneous Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. UAE C1 Esterase Inhibitor Subcutaneous Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Global Sales Market Share of C1 Esterase Inhibitor Subcutaneous by Type (2020-2031)

Figure 52. Global Revenue Market Share of C1 Esterase Inhibitor Subcutaneous by Type (2020-2031)

Figure 53. Global C1 Esterase Inhibitor Subcutaneous Price (US$/Unit) by Type (2020-2031)

Figure 54. Global Sales Market Share of C1 Esterase Inhibitor Subcutaneous by Application (2020-2031)

Figure 55. Global Revenue Market Share of C1 Esterase Inhibitor Subcutaneous by Application (2020-2031)

Figure 56. Global C1 Esterase Inhibitor Subcutaneous Price (US$/Unit) by Application (2020-2031)

Figure 57. C1 Esterase Inhibitor Subcutaneous Value Chain

Figure 58. Channels of Distribution (Direct Vs Distribution)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Drugs for HAE Market Research Report 2024

Global HAE Treatments Market Research Report 2024

Global C1 Esterase Inhibitors Market Research Report 2024

C1 Esterase Inhibitor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global C1 INH Replacement Therapy Market Research Report 2024

Global Icatibant Acetate Injection Market Research Report 2024

Global Hereditary Angioedema Therapeutic Market Insights Forecast to 2030

Global Icatibant Acetate API Market Research Report 2024

Global Icatibant Acetate Market Research Report 2024

C5 Complement Inhibitor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hereditary Angioedema Treatment Market Insights Forecast to 2030

Global Complement Protein C3 Inhibitors Market Research Report 2024

Global Complement Inhibitors Market Research Report 2024

Subcutaneous Allergy Immunotherapies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Angioedema Treatment Market Insights Forecast to 2030

Global Subcutaneous Immunotherapy Market Research Report 2024

Global Pegcetacoplan Injection Market Research Report 2024

Immune Globulin Subcutaneous Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cutaneous Lupus Erythematosus CLE Treatment Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions